* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Measure #198 (NQF 0079): Heart Failure: Left Ventricular Ejection
Coronary artery disease wikipedia , lookup
Electrocardiography wikipedia , lookup
Remote ischemic conditioning wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Myocardial infarction wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Cardiac surgery wikipedia , lookup
Heart failure wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Ventricular fibrillation wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Measure #198 (NQF 0079): Heart Failure: Left Ventricular Ejection Fraction (LVEF) Assessment 2014 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION: P ercentage of patients aged 18 years and older with a diagnosis of heart failure for whom the quantitative or qualitative results of a recent or prior [any time in the past] LVE F assessment is documented within a 12 month period INSTRUCTIONS: This measure is to be reported a minimum of once per reporting period for patients with heart failure seen during the reporting period, regardless of when the evaluation of left ventricular function was performed. This measure is intended to reflect the quality of services provided for the primary management of patients with heart failure. This measure may be reported by clinicians who perform the quality actions described based on the services provided and the measure-specific denominator coding. Only patients who had at least two denominator eligible visits during the reporting period will be counted into the denominator of this measure. Measure Reporting via Registry: ICD-9-CM/ICD-10-CM diagnosis codes, CP T codes and patient demographics are used to identify patients who are included in the measure’s denominator. The listed numerator options are used to report the numerator of the measure. The quality-data codes listed do not need to be submitted for registry-based submissions; however, these codes may be submitted for those registries that utilize claims data. There are no allowable performance exclusions for this measure. DENOMINATOR: All patients aged 18 years and older with a diagnosis of heart failure Denominator Criteria (Eligible Cases): Patients aged ≥ 18 years on date of encounter AND Diagnosis for heart failure (ICD-9-CM) [for use 1/1/2014-9/30/2014]: 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 428.0, 428.1, 428.20, 428.21, 428.22, 428.23, 428.30, 428.31, 428.32, 428.33, 428.40, 428.41, 428.42, 428.43, 428.9 Diagnosis for heart failure (ICD-10-CM) [for use 10/01/2014-12/31/2014]: I11.0, I13.0, I13.2, I50.1, I50.20, I50.21, I50.22, I50.23, I50.30, I50.31, I50.32, I50.33, I50.40, I50.41, I50.42, I50.43, I50.9 AND Patient encounter during the reporting period (CPT): 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, 99337, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350 AND Two Denominator Eligible Visits NUMERATOR: P atients for whom the quantitative or qualitative results of a recent or prior [any time in the past] LVEF assessment is documented within a 12 month period Version 8.0 CPT only copyright 2013 American Medical Association. All rights reserved. 12/13/13 403 of 613 NUMERATOR NOTE: LVEF < 40% corresponds to qualitative documentation of moderate dysfunction or severe dysfunction. The LVSD may be determined by quantitative or qualitative assessment, which may be current or historical. E xamples of a quantitative or qualitative assessment may include an echocardiogram: 1) that provides a numerical value of LVSD or 2) that uses descriptive terms such as moderately or severely Numerator Instructions: Documentation must include documentation in a progress note of the results of an LVE F assessment, regardless of when the evaluation of ejection fraction was performed. Definition: Qualitative Results Correspond to Numeric Equivalents as Follows: Hyperdynamic: corresponds to LVEF greater than 70% Normal: corresponds to LVE F 50% to 70% (midpoint 60%) Mild dysfunction: corresponds to LVE F 40% to 49% (midpoint 45%) Moderate dysfunction: corresponds to LVEF 30% to 39% (midpoint 35%) Severe dysfunction: corresponds to LVE F less than 30% Numerator Options: Left ventricular ejection fraction (LVE F) < 40% or documentation of severely or moderately depressed left ventricular systolic function (G8738) OR OR Left ventricular ejection fraction (LVEF) ≥ 40% or documentation as normal or mildly depressed left ventricular systolic function (G8739) Left ventricular ejection fraction (LVE F) not performed or assessed, reason not given (G8740) RATIONALE: Evaluation of LVEF in patients with heart failure provides important information that is required to appropriately direct treatment. Several pharmacologic therapies have demonstrated efficacy in slowing disease progression and improving outcomes in patients with left ventricular systolic dysfunction. LVE F assessed during the initial evaluation of patients presenting with heart failure can be considered valid unless the patient has demonstrated a major change in clinical status, experienced or recovered from a clinical event, or received therapy that might have a significant effect on cardiac function. A comprehensive 2-dimensional echocardiogram with Doppler flow studies has been identified as the single most useful diagnostic test in the evaluation of patients with heart failure. CLINICAL RECOMMENDATION STATEMENTS: The following evidence statements are quoted verbatim from the referenced clinical guidelines: Two-dimensional echocardiography with Doppler should be performed during initial evaluation of patients presenting with HF to assess LVEF, LV size, wall thickness, and valve function. R adionuclide ventriculography can be performed to assess LVE F and volumes. Radionuclide ventriculography can be performed to assess LVE F and volumes. (Class I, Level of Evidence: C) (ACC/AHA, 2009) Magnetic resonance imaging or computed tomography may be useful in evaluating chamber size and ventricular mass, detecting right ventricular dysplasia, or recognizing the presence of pericardial disease, as well as in assessing cardiac function and wall motion. (ACCF/AHA, 2009) Version 8.0 CPT only copyright 2013 American Medical Association. All rights reserved. 12/13/13 404 of 613